Actualités LakeShore Biopharma Company Ltd - LSB | Actions NASDAQ

LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance

LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance PR...

LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China

BEIJING, Dec. 12, 2024 (GLOBE NEWSWIRE) -- LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) (“LakeShore Biopharma”...

LakeShore Biopharma Initiates Biologics License Application of PIKA Rabies Vaccine to the Drug Regulatory Authority of Pakistan

GAITHERSBURG, Md., Nov. 07, 2024 (GLOBE NEWSWIRE) -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) (“LakeShore...

LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement PR Newswire GAITHERSBURG...

LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine

LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies...

LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance

LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance PR Newswire GAITHERSBURG...

LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation

LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation PR...

Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024

Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024 PR Newswire GAITHERSBURG, Md., Sept. 10, 2024...

LakeShore Biopharma Announces Leadership Transitions

LakeShore Biopharma Announces Leadership Transitions PR Newswire GAITHERSBURG, Md., Sept. 4, 2024...

LakeShore Biopharma Announces Financial Results for Fiscal Year 2024

LakeShore Biopharma Announces Financial Results for Fiscal Year 2024 PR Newswire GAITHERSBURG, Md., Aug. 15...

LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders' Requisition

LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders...

Directorate Change

ANNOUNCEMENT APPOINTMENT OF A NEW DIRECTOR London Scottish Bank plc has today appointed Alan Benzie as a non-executive Director of the Company...

Final Results

Preliminary Announcement of Final Results for the year ended 31 October 2003 Strong final results; good profit growth across all divisions 14...

Notice of Results

LONDON SCOTTISH BANK PUBLIC LIMITED COMPANY NOTIFICATION OF BOARD MEETING The Board of London Scottish Bank plc will be announcing its results...

Blocklisting - Interim Review

SCHEDULE 5 BLOCKLISTING SIX MONTHLY RETURN 1. Name of company LONDON SCOTTISH BANK PUBLIC LIMITED COMPANY 2. Name of scheme LONDON SCOTTISH...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

LakeShore Biopharma Company Ltd (LSB)

Outils de qualité professionnelle, pour des investisseurs individuels.

LSB Actualités